Efficiency, Productivity and Efficacy – when delivered reproducibly, can accelerate your Therapy
Explore our Systems
High performance electroporation platform for small to medium scale production of transiently expressed proteins
- High efficiency and viability improves protein yields
- Enhanced productivity reduces cell culture requirements
- Rapidly transfect from 75 thousand to 700 million cells
- Compatible with all MaxCyte static electroporation Processing Assemblies
- Perfect platform for faster production of stable clones
The next generation of the industry’s leading, clinically validated and scalable electroporation technology for complex cellular engineering.
- Rapidly transfect from 75 thousand to 20 billion cells
- 21CFR Part 11 enabled software
- Established regulatory path supported by FDA Master File
- Closed, cGMP-compliant, ISO-certified and CE-marked
- MaxCyte’s proprietary Flow Electroporation™ Technology
The industry’s leading scalable electroporation technology for high yield transient expression of complex proteins, vaccines and biologics.
- Rapidly transfect from 75 thousand to 20 billion cells
- High efficiency with flexible media strategies deliver significant cost savings
- Improved yields, at scale, can decrease development timelines
- Proprietary Flow Electroporation™ Technology
- Faster production of stable clones
- ISO-certified, and CE-marked
Our Vision
ENABLE COMPLEX CELLULAR ENGINEERING TO TRANSFORM THE LIVES OF PATIENTS
Contact
Find out how the ExPERT platform can help accelerate your research needs!
[contact-form-7 id="7" title="Contact form 1"]